ClearBridge Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

ClearBridge Investments’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-98	Closed	-$1K	–	1175
2018 Q1	$1K	Hold	98	–	–	﹤0.01%	1134
2017 Q4	$1K	Sell	98 -2,406	-96%	-$31.4K	﹤0.01%	1144
2017 Q3	$33K	Buy	2,504 +313	+14%	+$4.31K	﹤0.01%	944
2017 Q2	$35K	Buy	2,191 +412	+23%	+$5.99K	﹤0.01%	912
2017 Q1	$25K	Buy	1,779 +912	+105%	+$12.5K	﹤0.01%	976
2016 Q4	$11K	Buy	867 +662	+323%	+$8.36K	﹤0.01%	1069
2016 Q3	$3K	Buy	+205	New	+$2.4K	﹤0.01%	1082

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments's IRWD Position: Q2 2018 in Review

ClearBridge Investments sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2018, closing a stake of 98 shares — an estimated $1K sold.

ClearBridge Investments first reported a position in IRWD in Q3 2016 and held it in 7 quarters. The position peaked at $35K in Q2 2017. 148 funds tracked by Wall St. Rank hold IRWD as of Q2 2018.

ClearBridge Investments reported no remaining Ironwood Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
ClearBridge Investments sold 98 Ironwood Pharmaceuticals shares in Q2 2018, an estimated $1K.
ClearBridge Investments first reported a position in Ironwood Pharmaceuticals in Q3 2016 and held it in 7 quarters.
ClearBridge Investments's Ironwood Pharmaceuticals position peaked at $35K in Q2 2017.
148 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2018.

Based on ClearBridge Investments's 13F filing for Q2 2018, filed 14 Aug 2018.